Multisite Implementation of COMPRENDO

NARecruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

January 11, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2028

Conditions
Pediatric Cancer
Interventions
OTHER

COMPRENDO Peer Navigation Intervention

"Parents randomized to the intervention, COMPRENDO, will receive culture, language, and health literacy-concordant pre-accrual, accrual, and post-accrual activities in person led by a peer navigator for up to 4 weeks. Visit 1 (V1) will provide anticipatory guidance and education on a) general concepts of pediatric cancer research (standard of care, clinical trials, randomization); b) informed consent/assent, research affiliations (e.g., Children's Oncology Group); c) clinical trial types (therapeutic, non-therapeutic); d) voluntariness; and e) frequently asked questions, resources. Navigators will follow a script supported by culture, language and health-literacy concordant handouts and graphic materials, decision aids, and short video-clips. Navigators also provide support with decision-making and answer parents' questions. Three follow-up peer navigator visits (V2, V3, V4) over 4 weeks are tailored to the parents' needs."

Trial Locations (4)

35243

NOT_YET_RECRUITING

Children's of Alabama/University of Alabama at Birmingham, Birmingham

92123

RECRUITING

Rady Children's Hospital San Diego/University of California San Diego Moores Cancer Center, San Diego

94609

RECRUITING

University of California San Francisco Benioff Children's Hospitals, San Francisco

02115

NOT_YET_RECRUITING

Dana Farber Cancer Institute/Boston Children's Hospital, Boston

All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Diego

OTHER